Trial intelligence / Profile preview

Darbepoetin Alfa for Anemia in Diabetic Nephropathy

NCT00907608Phase 2Terminated

Sponsor
The Chinese University of Hong Kong
Start
Dec 2007
Primary completion
May 2009
Modality
Erythropoietins, Colony Stimulating Factors
Countries
1
01

Overview

A Phase 2 trial of darbepoetin alfa in anemia, sponsored by The Chinese University of Hong Kong. Started Dec 2007; status: terminated.

02

Drugs

darbepoetin alfa
03

Conditions

anemia

Beyond the preview

Go deeper on NCT00907608.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00907608.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call